Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2329–2352 of 2,531 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Baseline Control Clear all

Conditions: Diabetes
Interventions: Diabetes Dashboard Intervention, Usual Diabetes Care; Behavioral
Lead sponsor: Baystate Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 399 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: Major Depressive Disorder (MDD)
Interventions: Nicotine transdermal patch, PET Scan with [18F] VAT; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Systemic Lupus Erythematosus
Interventions: Group B SLE one blood donation, Blood drawing only Group C, Group A SLE prospective study; Other · Drug
Lead sponsor: Oklahoma Medical Research Foundation; Other
Eligibility: 14 Years to 70 Years
Enrollment: 158 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma • Collegeville, Pennsylvania

Conditions: High Blood Pressure, Hypertension
Interventions: Team-Based Home Blood Pressure Monitoring; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 85 Years
Enrollment: 5,760 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Postpartum, Neuromuscular Adaptations, Abdominal Muscles, Pelvic Floor Dysfunctions, Physical Activity
Interventions: Progressive exercise, Active Straight Leg Raise Test, Active Straight Leg Raise Fatigue Task, Lower Extremity Strength Testing, Ultrasound imaging of abdominal wall, Pelvic Floor Muscle Strength Testing, Pelvic Floor Muscle Endurance Testing; Other · Diagnostic Test
Lead sponsor: Carroll University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Waukesha, Wisconsin

Conditions: Colorectal Neoplasms
Interventions: Stepped CRCS Interventions, Control; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 50 Years to 64 Years
Enrollment: 1,892 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pathogen Transmission, Patient Participation, Aging
Interventions: Clean Hands Accessible and Manageable for Patients; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 65 Years and older
Enrollment: 293 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: Atopic Dermatitis
Interventions: Placebo, ASLAN004; Drug
Lead sponsor: ASLAN Pharmaceuticals; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 24
States / cities: Birmingham, Alabama • Encino, California • Fountain Valley, California + 20 more

Conditions: Breast Cancer Risk
Interventions: Breast Cancer Risk Reduction Household Intervention; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 10 Years to 65 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Polycystic Ovary Syndrome (PCOS), Obstructive Sleep Apnea, Obesity
Interventions: Progesterone, testosterone, glucocorticoid, continuous positive airway pressure, Estrogen, Control; Drug · Device · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 75 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pediatric Obesity, Insulin Resistance, Mitochondrial Dysfunction
Interventions: Exercise, Lifestyle counseling; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 10 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Opioid-Related Disorders
Interventions: Education, Education with Reminder, Education + Disposal Bag, Education + Disposal Bag with Reminder; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: Not listed
Enrollment: 1,159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Intimate Partner Violence
Interventions: SHE Program; Behavioral
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 4
States / cities: Attleboro, Massachusetts • Akron, Ohio • Providence, Rhode Island + 1 more

Conditions: Peri-Implantitis
Interventions: Minocycline HCl Microspheres; Drug
Lead sponsor: OraPharma; Industry
Eligibility: 21 Years and older
Enrollment: 215 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 9
States / cities: Los Angeles, California • Gainsville, Florida • Augusta, Georgia + 6 more

Conditions: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Interventions: Satralizumab, Placebo; Drug · Other
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 12 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 15
States / cities: Birmingham, Alabama • Irvine, California • Aurora, Colorado + 12 more

Conditions: Dental Caries, Gingivitis
Interventions: oral health assessment, Questionnaires, Clinical Exam, Microbiological sampling, Monitoring Adherence, Varnish application, Consent, Educational Program; Other
Lead sponsor: Leonardo Marchini; Other
Eligibility: 21 Years to 120 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Child Obesity
Interventions: PCIT-Health; Behavioral
Lead sponsor: Central Michigan University; Other
Eligibility: 30 Months to 84 Months
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Mount Pleasant, Michigan

Conditions: HIV Infections
Interventions: Positive Peers mobile app; Other
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 13 Years to 34 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 7
States / cities: Van Nuys, California • Newark, New Jersey • Cincinnati, Ohio + 4 more

Conditions: Atrophic Vaginitis, Breast Cancer
Interventions: Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2024
U.S. locations: 5
States / cities: Basking Ridge, New Jersey • Commack, New York • New York, New York + 2 more

Conditions: Financial Hardship, Food Insecurity, Health Status
Interventions: Career Navigator Coaching; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Plaque Psoriasis
Interventions: Bimekizumab; Drug
Lead sponsor: UCB Biopharma SRL; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: High Point, North Carolina • Bexley, Ohio

Conditions: Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD), Metabolic Associated-dysfunction Steatohepatitis (MASH)
Interventions: Standard of care acceptance-based behavioral weight loss program, Occupational therapy dietary and lifestyle modifications; Behavioral
Lead sponsor: Grand Valley State University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Wyoming, Michigan

Conditions: Angiokeratomas
Interventions: PTX-022; Drug
Lead sponsor: Palvella Therapeutics, Inc.; Industry
Eligibility: 6 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Sherman Oaks, California • Dawsonville, Georgia • Las Vegas, Nevada + 1 more

Conditions: Chronic Lateral Epicondylosis
Interventions: Platelet Rich Plasma - Group 1, Corticosteroid Control - Group 2; Biological · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

An RCT Evaluation of a Diabetes Dashboard Team Model in Primary Care

PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.

Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)

Team-Based Home Blood Pressure Monitoring

Postpartum Exercise Intervention

Initiation of Colon Cancer Screening in Veterans or "Start Screening Now"

Clean Hands Accessible and Manageable for Patients (CHAMPs)

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition

Sex Steroids, Sleep, and Metabolic Dysfunction in Women

Intensive Exercise to Improve Mitochondrial Dysfunction in Pediatric Obesity

Evaluation of a Medication Disposal Program in Primary Care

Intervention for Battered Sheltered Women With Substance Use Randomized Trial

Arestin - Use in Subjects With Peri-Implantitis

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Oral Hygiene Intervention Pilot Study

Improving Parent-Child Interactions to Enhance Child Health

Positive Peers Intervention Clinical Trial

Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen

Economic Mobility Pilot

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)

PEAK Platelet Rich Plasma Injection Treatment for Chronic Lateral Epicondylosis